The Transcription Factor C/EBP-β Mediates Constitutive and LPS-Inducible Transcription of Murine SerpinB2

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Udofa, Ekemini A ^a   Stringer, Brett W ^b   Gade, Padmaja ^a   Mahony, Donna ^b,c   Buzza, Marguerite S ^a   Kalvakolanu, Dhananjaya V ^a   Antalis, Toni M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CIS ACTING ELEMENT; LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR 2; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE; GENE CONSTRUCT; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONEUM MACROPHAGE; PROMOTER REGION; REGULATORY SEQUENCE; REPORTER GENE; SEQUENCE HOMOLOGY; SERPINB2 GENE; ANIMAL; CELL LINE; CYTOLOGY; HUMAN; MACROPHAGE; METABOLISM; MOLECULAR GENETICS; MOUSE;

ANIMALS; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; CONSERVED SEQUENCE; DNA MUTATIONAL ANALYSIS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROMOTER REGIONS, GENETIC;

EID: 84874626573     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057855     Document Type: Article

References (81)

1. Cohen J, (2002) The immunopathogenesis of sepsis. Nature 420: 885-891.
2. Grivennikov SI, Greten FR, Karin M, (2010) Immunity, inflammation, and cancer. Cell 140: 883-899.
3. Grivennikov SI, Karin M, (2010) Inflammation and oncogenesis: a vicious connection. Curr.Opin.Genet.Dev. 20: 65-71.
4. Costelloe EO, Stacey KJ, Antalis TM, Hume DA, (1999) Regulation of the plasminogen activator inhibitor-2 (PAI-2) gene in murine macrophages. Demonstration of a novel pattern of responsiveness to bacterial endotoxin. J.Leukoc.Biol. 66: 172-182.
5. Schwartz BS, Bradshaw JD, (1992) Regulation of plasminogen activator inhibitor mRNA levels in lipopolysaccharide-stimulated human monocytes. Correlation with production of the protein. J.Biol.Chem. 267: 7089-7094.
6. Antalis TM, Clark MA, Barnes T, Lehrbach PR, Devine PL, et al. (1988) Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor. Proc.Natl.Acad.Sci.U.S.A 85: 985-989.
7. Vassalli JD, Sappino AP, Belin D, (1991) The plasminogen activator/plasmin system. J.Clin.Invest 88: 1067-1072.
8. Webb AC, Collins KL, Snyder SE, Alexander SJ, Rosenwasser LJ, et al. (1987) Human monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitor. J.Exp.Med. 166: 77-94.
9. Kruithof EK, Baker MS, Bunn CL, (1995) Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 86: 4007-4024.
10. Bird CH, Blink EJ, Hirst CE, Buzza MS, Steele PM, et al. (2001) Nucleocytoplasmic distribution of the ovalbumin serpin PI-9 requires a nonconventional nuclear import pathway and the export factor Crm1. Mol.Cell Biol. 21: 5396-5407.
11. Kumar S, Baglioni C, (1991) Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J.Biol.Chem. 266: 20960-20964.
12. Dickinson JL, Bates EJ, Ferrante A, Antalis TM, (1995) Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J.Biol.Chem. 270: 27894-27904.
13. Dickinson JL, Norris BJ, Jensen PH, Antalis TM, (1998) The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis. Cell Death.Differ. 5: 163-171.
14. Gan H, Newman GW, Remold HG, (1995) Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4. J.Immunol. 155: 1304-1315.
15. Antalis TM, La Linn M, Donnan K, Mateo L, Gardner J, et al. (1998) The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming. J.Exp.Med. 187: 1799-1811.
16. Park JM, Greten FR, Wong A, Westrick RJ, Arthur JS, et al. (2005) Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and NF-kappaB as key regulators. Immunity. 23: 319-329.
17. Bird PI, (1998) Serpins and regulation of cell death. Results Probl.Cell Differ. 24: 63-89.
18. Hibino T, Izaki S, Ohkuma M, Kon S, Thorsen S, et al. (1988) Epidermal plasminogen activator inhibitor (PAI) is immunologically identical to placental-type PAI-2. FEBS Lett. 231: 202-206.
19. Yu H, Maurer F, Medcalf RL, (2002) Plasminogen activator inhibitor type 2: a regulator of monocyte proliferation and differentiation. Blood 99: 2810-2818.
20. Lian X, Yang T, (2004) Plasminogen activator inhibitor 2: expression and role in differentiation of epidermal keratinocyte. Biol.Cell 96: 109-116.
21. Jensen PJ, Lavker RM, (1996) Modulation of the plasminogen activator cascade during enhanced epidermal proliferation in vivo. Cell Growth Differ. 7: 1793-1804.
22. Shafren DR, Gardner J, Mann VH, Antalis TM, Suhrbier A, (1999) Picornavirus receptor down-regulation by plasminogen activator inhibitor type 2. J.Virol. 73: 7193-7198.
23. Darnell GA, Antalis TM, Johnstone RW, Stringer BW, Ogbourne SM, et al. (2003) Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif. Mol.Cell Biol. 23: 6520-6532.
24. Varro A, Noble PJ, Pritchard DM, Kennedy S, Hart CA, et al. (2004) Helicobacter pylori induces plasminogen activator inhibitor 2 in gastric epithelial cells through nuclear factor-kappaB and RhoA: implications for invasion and apoptosis. Cancer Res. 64: 1695-1702.
25. Gan H, Lee J, Ren F, Chen M, Kornfeld H, et al. (2008) Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat.Immunol. 9: 1189-1197.
26. Losick VP, Isberg RR, (2006) NF-kappaB translocation prevents host cell death after low-dose challenge by Legionella pneumophila. J Exp.Med. 203: 2177-2189.
27. Schroder WA, Gardner J, Le TT, Duke M, Burke ML, et al. (2010) SerpinB2 deficiency modulates Th1Th2 responses after schistosome infection. Parasite Immunol. 32: 764-768.
28. Schroder WA, Le TT, Major L, Street S, Gardner J, et al. (2010) A physiological function of inflammation-associated SerpinB2 is regulation of adaptive immunity. J.Immunol. 184: 2663-2670.
29. Stasinopoulos S, Mariasegaram M, Gafforini C, Nagamine Y, Medcalf RL, (2010) The plasminogen activator inhibitor 2 transcript is destabilized via a multi-component 3' UTR localized adenylate and uridylate-rich instability element in an analogous manner to cytokines and oncogenes. FEBS J. 277: 1331-1344.
30. Antalis TM, Costelloe E, Muddiman J, Ogbourne S, Donnan K, (1996) Regulation of the plasminogen activator inhibitor type-2 gene in monocytes: localization of an upstream transcriptional silencer. Blood 88: 3686-3697.
31. Medcalf RL, (2011) Plasminogen activator inhibitor type 2: still an enigmatic serpin but a model for gene regulation. Methods Enzymol. 499: 105-134.
32. Suzuki T, Hashimoto S, Toyoda N, Nagai S, Yamazaki N, et al. (2000) Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE. Blood 96: 2584-2591.
33. Akira S, Takeda K, (2004) Toll-like receptor signalling. Nat.Rev.Immunol. 4: 499-511.
34. Roy SK, Hu J, Meng Q, Xia Y, Shapiro PS, et al. (2002) MEKK1 plays a critical role in activating the transcription factor C/EBP-beta-dependent gene expression in response to IFN-gamma. Proc.Natl.Acad.Sci.U.S.A 99: 7945-7950.
35. Dougherty KM, Pearson JM, Yang AY, Westrick RJ, Baker MS, et al. (1999) The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival. Proc.Natl.Acad.Sci.U.S.A 96: 686-691.
36. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR, (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51-59.
37. Cousin E, Medcalf RL, Bergonzelli GE, Kruithof EK, (1991) Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res. 19: 3881-3886.
38. Gade P, Roy SK, Li H, Nallar SC, Kalvakolanu DV, (2008) Critical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1. Mol.Cell Biol. 28: 2528-2548.
39. Buck M, Poli V, van der Geer P, Chojkier M, Hunter T, (1999) Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBP beta is required for hepatocyte proliferation induced by TGF alpha. Mol.Cell 4: 1087-1092.
40. Shuman JD, Sebastian T, Kaldis P, Copeland TD, Zhu S, et al. (2004) Cell cycle-dependent phosphorylation of C/EBPbeta mediates oncogenic cooperativity between C/EBPbeta and H-RasV12. Mol.Cell Biol. 24: 7380-7391.
41. Baer M, Johnson PF, (2000) Generation of truncated C/EBPbeta isoforms by in vitro proteolysis. J.Biol.Chem. 275: 26582-26590.
42. Chang S, Stacey KJ, Chen J, Costelloe EO, Aderem A, et al. (1999) Mechanisms of regulation of the MacMARCKS gene in macrophages by bacterial lipopolysaccharide. J.Leukoc.Biol. 66: 528-534.
43. Maurer F, Tierney M, Medcalf RL, (1999) An AU-rich sequence in the 3'-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR. Nucleic Acids Res. 27: 1664-1673.
44. Tierney MJ, Medcalf RL, (2001) Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs. J.Biol.Chem. 276: 13675-13684.
45. Bergonzelli GE, Kruithof EK, Medcalf RL, (1992) Transcriptional antagonism of phorbol ester-mediated induction of plasminogen activator inhibitor types 1 and 2 by cyclic adenosine 3',5'-monophosphate. Endocrinology 131: 1467-1472.
46. Xiao G, Liu YE, Gentz R, Sang QA, Ni J, et al. (1999) Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells. Proc.Natl.Acad.Sci.U.S.A 96: 3700-3705.
47. Stringer B, Udofa EA, Antalis TM (2012) Regulation of the human plasminogen activator inhibitor type 2 (PAI-2) gene: cooperation of an upstream silencer and transactivator. J.Biol.Chem.
48. Schleuning WD, Medcalf RL, Hession C, Rothenbuhler R, Shaw A, et al. (1987) Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells. Mol.Cell Biol. 7: 4564-4567.
49. Maurer F, Medcalf RL, (1996) Plasminogen activator inhibitor type 2 gene induction by tumor necrosis factor and phorbol ester involves transcriptional and post-transcriptional events. Identification of a functional nonameric AU-rich motif in the 3'-untranslated region. J Biol.Chem. 271: 26074-26080.
50. Antalis TM, Dickinson JL, (1992) Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells. Eur.J.Biochem. 205: 203-209.
51. Antalis TM, Godbolt D, Donnan KD, Stringer BW, (1993) Southwestern blot mapping of potential regulatory proteins binding to the DNA encoding plasminogen activator inhibitor type 2. Gene 134: 201-208.
52. Hardison RC, (2000) Conserved noncoding sequences are reliable guides to regulatory elements. Trends Genet. 16: 369-372.
53. Ye RD, Wun TC, Sadler JE, (1987) cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta. J.Biol.Chem. 262: 3718-3725.
54. Samia JA, Alexander SJ, Horton KW, Auron PE, Byers MG, et al. (1990) Chromosomal organization and localization of the human urokinase inhibitor gene: perfect structural conservation with ovalbumin. Genomics 6: 159-67.
55. Dear AE, Costa M, Medcalf RL, (1997) Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA. FEBS Lett. 402: 265-272.
56. Schuster WA, Medcalf RL, Kruithof EKO, (1994) Localization and Characterization of a Retinoic Acid Response-Like Element in the Plasminogen Activator Inhibitor-2 Gene Promoter. Fibrinolysis 8: 113-9.
57. Sweet MJ, Hume DA, (1996) Endotoxin signal transduction in macrophages. J.Leukoc.Biol. 60: 8-26.
58. Sekine H, Mimura J, Oshima M, Okawa H, Kanno J, et al. (2009) Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock. Mol.Cell Biol. 29: 6391-6400.
59. Poli V, (1998) The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J.Biol.Chem. 273: 29279-29282.
60. Kalvakolanu DV, Roy SK, (2005) CCAAT/enhancer binding proteins and interferon signaling pathways. J.Interferon Cytokine Res. 25: 757-769.
61. Hirai H, Zhang P, Dayaram T, Hetherington CJ, Mizuno S, et al. (2006) C/EBPbeta is required for 'emergency' granulopoiesis. Nat.Immunol. 7: 732-739.
62. Bradley MN, Zhou L, Smale ST, (2003) C/EBPbeta regulation in lipopolysaccharide-stimulated macrophages. Mol.Cell Biol. 23: 4841-4858.
63. Tsukada J, Yoshida Y, Kominato Y, Auron PE, (2011) The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation. Cytokine 54: 6-19.
64. Spooner CJ, Sebastian T, Shuman JD, Durairaj S, Guo X, et al. (2007) C/EBPbeta serine 64, a phosphoacceptor site, has a critical role in LPS-induced IL-6 and MCP-1 transcription. Cytokine 37: 119-127.
65. Buck M, Chojkier M, (2007) C/EBPbeta phosphorylation rescues macrophage dysfunction and apoptosis induced by anthrax lethal toxin. Am.J.Physiol Cell Physiol 293: C1788-C1796.
66. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, et al. (1993) Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc.Natl.Acad.Sci.U.S.A 90: 10193-10197.
67. Niehof M, Manns MP, Trautwein C, (1997) CREB controls LAP/C/EBP beta transcription. Mol.Cell Biol. 17: 3600-3613.
68. Uematsu S, Kaisho T, Tanaka T, Matsumoto M, Yamakami M, et al. (2007) The C/EBP beta isoform 34-kDa LAP is responsible for NF-IL-6-mediated gene induction in activated macrophages, but is not essential for intracellular bacteria killing. J.Immunol. 179: 5378-5386.
69. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, et al. (1995) Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80: 353-361.
70. Lekstrom-Himes J, Xanthopoulos KG, (1998) Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J.Biol.Chem. 273: 28545-28548.
71. Ramji DP, Foka P, (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem.J. 365: 561-575.
72. Schrem H, Klempnauer J, Borlak J, (2004) Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol.Rev. 56: 291-330.
73. Roy SK, Shuman JD, Platanias LC, Shapiro PS, Reddy SP, et al. (2005) A role for mixed lineage kinases in regulating transcription factor CCAAT/enhancer-binding protein-{beta}-dependent gene expression in response to interferon-{gamma}. J.Biol.Chem. 280: 24462-24471.
74. Karin M, Lawrence T, Nizet V, (2006) Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124: 823-835.
75. Karin M, Greten FR, (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat.Rev.Immunol. 5: 749-759.
76. DiDonato JA, Mercurio F, Karin M, (2012) NF-kappaB and the link between inflammation and cancer. Immunol.Rev. 246: 379-400.
77. Croucher DR, Saunders DN, Lobov S, Ranson M, (2008) Revisiting the biological roles of PAI2 (SERPINB2) in cancer. Nat.Rev.Cancer 8: 535-545.
78. Schroder WA, Major L, Suhrbier A, (2011) The role of SerpinB2 in immunity. Crit Rev.Immunol. 31: 15-30.
79. Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, et al. (2007) NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130: 918-931.
80. Marigo I, Bosio E, Solito S, Mesa C, Fernandez A, et al. (2010) Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity. 32: 790-802.
81. Screpanti I, Romani L, Musiani P, Modesti A, Fattori E, et al. (1995) Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J. 14: 1932-1941.